265 related articles for article (PubMed ID: 17661735)
1. Nebivolol: third-generation beta-blockade.
de Boer RA; Voors AA; van Veldhuisen DJ
Expert Opin Pharmacother; 2007 Jul; 8(10):1539-50. PubMed ID: 17661735
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
Moen MD; Wagstaff AJ
Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
Agabiti Rosei E; Rizzoni D
Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
[TBL] [Abstract][Full Text] [Related]
4. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
Kamp O; Metra M; Bugatti S; Bettari L; Dei Cas A; Petrini N; Dei Cas L
Drugs; 2010; 70(1):41-56. PubMed ID: 20030424
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
Del Sindaco D; Tinti MD; Monzo L; Pulignano G
Clin Interv Aging; 2010 Dec; 5():381-93. PubMed ID: 21152240
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
9. Nebivolol: a review.
Cockcroft J
Expert Opin Pharmacother; 2004 Apr; 5(4):893-9. PubMed ID: 15102571
[TBL] [Abstract][Full Text] [Related]
10. A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.
Cockcroft J
Vasc Health Risk Manag; 2007; 3(6):909-17. PubMed ID: 18200810
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol: impact on cardiac and endothelial function and clinical utility.
Toblli JE; DiGennaro F; Giani JF; Dominici FP
Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
[TBL] [Abstract][Full Text] [Related]
13. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
[No Abstract] [Full Text] [Related]
14. Beta-blockers in the management of hypertension: focus on nebivolol.
Wojciechowski D; Papademetriou V
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol.
Kuroedov A; Cosentino F; Lüscher TF
Cardiovasc Drug Rev; 2004; 22(3):155-68. PubMed ID: 15492765
[TBL] [Abstract][Full Text] [Related]
16. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
17. Nebivolol for the treatment of heart failure.
Riva N; Lip GY
Expert Opin Investig Drugs; 2011 Dec; 20(12):1733-46. PubMed ID: 21980961
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol: a new antihypertensive agent.
Gray CL; Ndefo UA
Am J Health Syst Pharm; 2008 Jun; 65(12):1125-33. PubMed ID: 18541682
[TBL] [Abstract][Full Text] [Related]
20. Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker.
Gao Y; Vanhoutte PM
J Cardiovasc Pharmacol; 2012 Jan; 59(1):16-21. PubMed ID: 21283024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]